Marianne E Greene - JoVE Visualize

Showing results (1-10 of 7) with videos related to

Pageof 1

Sort By:

Blood|February 1, 2003

Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesisGina Mundschau, Sandeep Gurbuxani, Alan S Gamis, et al.

Oncogene|February 6, 2003

Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivoRobyn Karnauskas, Qun Niu, Sunit Talapatra, et al.

Blood Cells, Molecules & Diseases|November 26, 2003

Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndromeMarianne E Greene, Gina Mundschau, Joshua Wechsler, et al.

Breast Cancer Research : BCR|June 7, 2024

Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancerMuriel Lainé, Marianne E Greene, Justyna D Kurleto, et al.

Breast Cancer Research : BCR|May 13, 2021

Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancerMuriel Lainé, Sean W Fanning, Ya-Fang Chang, et al.

Science Advances|July 8, 2016

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancerHari Singhal, Marianne E Greene, Gerard Tarulli, et al.

Oncotarget|February 14, 2018

Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signalingHari Singhal, Marianne E Greene, Allison L Zarnke, et al.

Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:

Pageof 1

Blood|February 1, 2003

Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesisGina Mundschau, Sandeep Gurbuxani, Alan S Gamis, et al.

Oncogene|February 6, 2003

Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivoRobyn Karnauskas, Qun Niu, Sunit Talapatra, et al.

Blood Cells, Molecules & Diseases|November 26, 2003

Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndromeMarianne E Greene, Gina Mundschau, Joshua Wechsler, et al.

Breast Cancer Research : BCR|June 7, 2024

Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancerMuriel Lainé, Marianne E Greene, Justyna D Kurleto, et al.

Breast Cancer Research : BCR|May 13, 2021

Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancerMuriel Lainé, Sean W Fanning, Ya-Fang Chang, et al.

Science Advances|July 8, 2016

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancerHari Singhal, Marianne E Greene, Gerard Tarulli, et al.

Oncotarget|February 14, 2018

Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signalingHari Singhal, Marianne E Greene, Allison L Zarnke, et al.

Pageof 1